Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Neoplasms Phase 1 ClinicalTrials
Hodgkin Disease; Lymphoma Phase 2 ClinicalTrials
CONTENTS